Avid Bioservices Inc

General ticker "CDMO" information:

  • Sector: Health Care
  • Industry: Biotechnology
  • Capitalization: $793.3M

Avid Bioservices Inc follows the US Stock Market performance with the rate: 53.9%.

Estimated limits based on current volatility of 0.1%: low 12.49$, high 12.50$

Factors to consider:

  • Company does not operate outside North America (retrieved using AI)
  • Earnings for 6 months up through Q2 are below our estimates

Stock Forecast*

* forecast is subjective and experimental, should not be used for any investment decisions

Long term estimates were made for the period from 2024-04-30 to 2026-04-30

  • 2024-04-30 to 2025-04-30 estimated range: [4.80$, 9.62$]
  • 2025-04-30 to 2026-04-30 estimated range: [4.76$, 9.55$]

Financial Metrics affecting the CDMO estimates:

  • Negative: Non-GAAP EPS, $ of -0.30 <= 0
  • Negative: negative Operating income
  • Negative: negative Net income
  • Negative: Industry operating cash flow per share per price (median), % of -24.29 <= 2.98
  • Positive: Inventory ratio change, % of -10.57 <= -1.08

Similar symbols

Short-term CDMO quotes

Long-term CDMO plot with estimates

Financial data

YTD 2022-04-30 2023-04-30 2024-04-30
Operating Revenue $119.60MM $149.27MM $139.91MM
Operating Expenses $104.17MM $145.66MM $158.59MM
Operating Income $15.42MM $3.60MM $-18.68MM
Non-Operating Income $-2.76MM $-1.60MM $-8.25MM
Interest Expense $2.68MM $2.60MM $4.34MM
Income(Loss) $12.66MM $2.00MM $-26.93MM
Taxes $-115.01MM $1.44MM $113.83MM
Profit(Loss)* $127.67MM $0.56MM $-140.75MM
Stockholders Equity $174.53MM $189.47MM $60.89MM
Inventory $26.06MM $43.91MM $30.38MM
Assets $429.84MM $451.05MM $336.56MM
Operating Cash Flow $9.46MM $-12.89MM $10.95MM
Capital expenditure $56.41MM $77.64MM $31.80MM
Investing Cash Flow $-56.41MM $-77.64MM $-31.80MM
Financing Cash Flow $3.20MM $2.90MM $20.07MM
Earnings Per Share** $2.08 $0.01 $-2.23

* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.